Call for Application to Researchers for Joint Research Project between Ono Pharmaceutical and BioMed X

- Research Theme: New Strategies to Engage Neurophils in Solid Tumors -

OSAKA, Japan, Jan. 9, 2024 /PRNewswire/ -- Ono Pharmaceutical Co., Ltd. (Osaka, Japan) informed that it has started a new collaboration with BioMed X (Heidelberg, Germany) on cancer immunotherapies and has been inviting researchers who are interested in this research project via BioMed X.

For details, please refer to the following BioMed X press release and application guidelines for the research project:

BioMed X's press release dated December 19, 2023: 
BioMed X Institute and Ono Pharmaceutical Launch New Collaboration in Cancer Research

Application guidelines for the research project: 
Call for Application #2023-BMX-C03 open until February 18, 2024

(Summary of applications) For more information, please refer to the above link.
Research theme:                    New Strategies to Engage Neutrophils in Solid Tumors
Project term:                           3 - 5 years
Deadline for applications:       February 18, 2024

Logo - https://mma.prnewswire.com/media/1636289/ONO_PHARMA_USA_Logo.jpg